Command Palette

Search for a command to run...

Clinical Trials · NCT01628445

Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin

TerminatedPhase 3Liraglutide (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
University of Manitoba
Enrollment
52
Start date
Aug 2012
Locations
1 site, Canada
Primary endpoint
Change in A1c
View Liraglutide compound reference